A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)

NCT02749630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Crohn's Disease

Interventions

DRUG: Placebo
DRUG: UTTR1147A

Sponsor

Genentech, Inc.